October 15, 2020 by matray

Curi today announced that Jason Sandner will be its next chief executive officer. Sandner will officially take the helm on July 1, 2021, when current CEO Dale Jenkins steps down after more than 25 years of service to the company. Jenkins will continue to serve on Curi’s Board of Directors.

Currently Curi’s chief operating officer and chief financial officer, Sandner was selected following a multi-month, nationwide search led by Curi’s Board of Directors with the assistance of executive search firm Heidrick & Struggles. A senior executive with two decades of financial, operational and managerial expertise, Sandner has managed the financial strategy of Curi and its affiliates for more than a decade.

“We believe Jason Sandner will help the company deliver ever-greater success to our member community,” said Dr. Robert Schaaf, Curi’s Board chairperson. “We looked for someone who has a passion for serving doctors and believes in the vision and strategy we’re aggressively pursuing. Jason is an extremely capable leader, and our search process proved to us that he is the very best person to lead Curi into the future.”

Sandner joined Curi in 2011 as its vice president of finance, was promoted to chief financial officer and recently took on the role of chief operating officer as well.

“Jason has had a strong positive impact on Curi and the broader physician community over the years, and I’m thrilled that the Board chose him to be my successor,” Jenkins said. “We’re a purpose-driven team here at Curi, passionately curious about new ways to improve our offerings for physicians and their practices, and Jason is a wonderful embodiment of that spirit. He believes deeply in what we do, and he sees opportunities for Curi to keep getting better in the future.”

“It has been incredibly rewarding to be part of Curi’s growth and evolution over the years, especially alongside leaders like Dale and our physician colleagues on the Board,” Sandner said. “I’m honored to have the opportunity to lead the company and our team into this next phase of growth in support of our mission to help physicians in medicine, business and life.”